Ocumension Therapeutics
HKEX:1477

Watchlist Manager
Ocumension Therapeutics Logo
Ocumension Therapeutics
HKEX:1477
Watchlist
Price: 5.08 HKD -3.97% Market Closed
Market Cap: 4.1B HKD
Have any thoughts about
Ocumension Therapeutics?
Write Note

Ocumension Therapeutics
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ocumension Therapeutics
Research & Development Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Ocumension Therapeutics
HKEX:1477
Research & Development
-ÂĄ114.8m
CAGR 3-Years
14%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Research & Development
-ÂĄ2.1B
CAGR 3-Years
-19%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Research & Development
-ÂĄ232.3m
CAGR 3-Years
-31%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Research & Development
-ÂĄ5.7B
CAGR 3-Years
0%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Research & Development
-ÂĄ339.2m
CAGR 3-Years
-19%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Research & Development
-ÂĄ712.5m
CAGR 3-Years
-61%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ocumension Therapeutics's Research & Development?
Research & Development
-114.8m CNY

Based on the financial report for Dec 31, 2023, Ocumension Therapeutics's Research & Development amounts to -114.8m CNY.

What is Ocumension Therapeutics's Research & Development growth rate?
Research & Development CAGR 5Y
-23%

Over the last year, the Research & Development growth was 38%. The average annual Research & Development growth rates for Ocumension Therapeutics have been 14% over the past three years , -23% over the past five years .

Back to Top